CanFinis Therapeutics, an oncology research and cell therapy start-up based in Kolkata, was founded by leading technology experts, entrepreneurs, and clinicians. The company has developed an innovative tumor microenvironment platform that tests the efficacy of both standard care drugs and novel molecules ex vivo at the preclinical stage. This platform is utilized by oncology drug discovery companies. Additionally, CanFinis is working on pioneering CAR-T therapies targeting solid tumors prevalent in India and Southeast Asia. The company is poised for a potential collaboration to develop and commercialize a novel CAR-T product in India and Southeast Asia. CanFinis aims to enhance CAR-T therapies by leveraging a deep understanding of patient tumor antigens to optimize treatments, reduce time, and cut costs. With its advanced tumor microenvironment platform and CAR-T innovations, CanFinis is set to transform patient care and establish a significant market for personalized cancer treatments by integrating global talent and technologies.

demo01-img-02

Affordable Treatment

Develop affordable novel CAR-Ts for solid cancer treatment

Market Growth & Opportunity

Estimated at ~USD 150 billion, projected to exceed USD 400 billion by 2027.

Why support us?

We are a Life Sciences Start-Up

CanFinis boasts a highly qualified team adept in cutting-edge CAR-T therapy development. With diverse expertise spanning oncology, biotechnology, and entrepreneurship, our team is committed to revolutionizing cancer treatment. Together, we're driven to deliver innovative solutions for patients worldwide

Qualified Team

CanFinis boasts a highly qualified team adept in cutting-edge CAR-T therapy development

Tailored Precision

Precision-engineered CAR-T treatments tailored to individual patients for enhanced efficacy and outcomes

Breaking Barriers

Advancing CAR-T therapy to target solid tumors, overcoming previous limitations for broader cancer treatment

Revolutionizing Treatment

Testing Efficacy with Cutting-edge Tumor Microenvironment Platform

CanFinis

OUR VISION

Our vision at CanFinis is simple yet profound: every cancer patient deserves access to cutting-edge technologies and modern medicines at an affordable cost. We're dedicated to making this vision a reality by pioneering innovative therapies that prioritize both efficacy and accessibility for everyone

CanFinis

OUR MISSION

At CanFinis, our mission is to introduce state-of-the-art technologies for personalized cancer treatments targeting both hematological and solid cancers. Through innovation and dedication, we strive to advance the field of cancer treatment, offering tailored solutions to improve patient outcomes and quality of life

Team member

Co-Founders

{"cpt":"team","style":"1","columns":"3","show":3,"from_category":["cofounders"],"order":"DESC","orderby":"none"}
CanFinis boasts a highly qualified team adept in cutting-edge CAR-T therapy and drug development. With diverse expertise spanning oncology, biotechnology, clinical research and entrepreneurship, our team is committed to revolutionizing cancer treatment. Together, we're driven to deliver innovative solutions for the cancer patients worldwide.
Loader
All content loaded

Team member

Clinical Advisory Board

{"cpt":"team","style":"1","columns":"3","show":3,"from_category":["clinical-advisory-board"],"order":"DESC","orderby":"none"}
Loader
All content loaded
{"cpt":"team","style":"1","columns":"3","show":3,"from_category":["scientific-advisory-board"],"order":"DESC","orderby":"none"}

Team member

Scientific Advisory Board

Loader
All content loaded

About Us

Have any question +91 8861410623

Copyright © 2024 CANFINIS, All Rights Reserved.